Results 221 to 230 of about 9,613,246 (402)
Remission of Graves' Disease Through Lifestyle Interventions. [PDF]
Sharma P.
europepmc +1 more source
Triiodothyronine, Thyroxine, and Iodine in Purified Thyroglobulin from Patients with Graves' Disease [PDF]
Motomori Izumi, P. Reed Larsen
openalex +1 more source
Lecithin Alleviates Memory Deficits and Muscle Attenuation in Chinese Older Adults and SAMP8 Mice
This study opens a new avenue for safeguarding cognition and muscle health, averting disability in older age, and treating age‐related pathologies through lecithin supplementation. It serves as a promising nonpharmacological intervention for the crosstalk of muscle and cognition.
Xianyun Wang+16 more
wiley +1 more source
Management of Graves Disease With Co-Existing Duffy-Null Phenotype. [PDF]
Ferri GM+5 more
europepmc +1 more source
Advances in Microfluidic Cochlea‐On‐A‐Chip
This review systematically examines diverse cell sources for inner ear organoids and outlines stepwise induction protocols. Furthermore, it discusses current applications and prospective developments of cochlea‐on‐a‐chip technologies in areas such as deafness modeling, mechanistic studies, and drug evaluation, with particular focus on gene‐therapy drug
Tian Shen+10 more
wiley +1 more source
Massive Thymic Hyperplasia in Graves Disease. [PDF]
Chan C, Ryder S, Luong D, Puri G.
europepmc +1 more source
Data from a prospective cohort with 112 auditory brainstem implant users are analyzed. Younger age at implantation (<3 years), less severe inner‐ear malformation (common cavity, cochlear aplasia, and hypoplasia), and more intraoperative eABR evoked electrodes (≥60%) are associated with better hearing and speech outcomes.
Yu Zhang+11 more
wiley +1 more source